Koers Sirona Biochem Corp. Other OTC
Aandelen
SRBCF
CA82967M1005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 672K 492K 453K | Omzet 2023 | 34,78K 25,47K 23,47K | Marktkapitalisatie | 21,44 mln. 15,7 mln. 14,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,2 mln. -2,02 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,46 mln. -1,35 mln. | EV/omzet 2022 | 48,8 x |
Nettoschuld 2022 | 48,04K 35,18K 32,41K | Nettoschuld 2023 | 1,61 mln. 1,18 mln. 1,09 mln. | EV/omzet 2023 | 663 x |
K/w-verhouding 2022 |
-8,81
x | K/w-verhouding 2023 |
-8,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 89,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,42% | 63,85 mld. | |
-2,32% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,41% | 26,52 mld. | |
-21,55% | 18,69 mld. | |
+2,83% | 12,73 mld. | |
+22,06% | 12,11 mld. | |
+27,58% | 12,07 mld. |